At a glance
- Originator Servier
- Class Vascular disorder therapies; Vasoprotectives
- Mechanism of Action Alpha adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Venous insufficiency
Most Recent Events
- 13 Mar 2000 No-Development-Reported for Venous insufficiency in France (Unknown route)
- 20 Feb 1997 New profile
- 20 Feb 1997 Preclinical development for Venous insufficiency in France (Unknown route)